Jeffrey M. Jonas, Director at Karuna Therapeutics, Inc. (KRTX), sold 27,620 shares at $217.82 ($6.0M) on 2023-07-03, disclosed to the SEC on 2023-07-05.
Scheduled sale ($6.0M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $214.61 | 234 | $50K | 0.8% |
| 2 | $214.61 | 234 | $50K | 0.8% |
| 3 | $215.91 | 7,966 | $1.7M | 28.8% |
| 4 | $215.91 | 7,966 | $1.7M | 28.8% |
| 5 | $216.78 | 3,201 | $694K | 11.6% |
| 6 | $216.78 | 3,201 |
| $694K |
| 11.6% |
| 7 | $217.82 | 2,409 | $525K | 8.8% |
| 8 | $217.82 | 2,409 | $525K | 8.8% |
| Total | $216.42 avg | 27,620 | $6.0M | 100% |
| Filing → |
| SAGE | SELL | 2023-02-10 | $1.0M | — | Filing → |
| SAGE | BUY | 2019-12-10 | $482K | — | Filing → |
| SAGE | SELL | 2019-05-29 | $29.9M | — | Filing → |